Skip to main content

UBS Group AG

Position in CHRS — Coherus Oncology, Inc.

CIK 1610520 ZURICH, V8

Position in CHRS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,064,500
+$139,718 QoQ
Shares Held
760,358
+39.0% QoQ
Ownership
0.492%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 147 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CHRS Over Time

Shares Held

Position Value (USD)

Derivatives in CHRS

reported options exposure · as of Mar 31, 2020
CallValue
$0
CallShares
0
PutValue
$324,400
PutShares
20,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. CHRS ranks #262 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CHRS

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,064,500 760,358
2026-03-31 $924,782 547,209
2025-12-31 $867,338 610,803
2025-09-30 $1,305,342 795,941
2025-06-30 $419,981 574,531
2025-03-31 $297,742 368,951
2024-12-31 $978,417 708,999
2024-09-30 $180,094 173,169
2024-06-30 $320,982 185,540
2024-03-31 $291,269 121,870
2023-12-31 $480,605 144,326
2023-09-30 $1,156,075 309,111
2023-06-30 $9,192 2,153
2023-03-31 $1,405,017 205,412
2022-12-31 $2,420,739 305,649
2022-09-30 $431,988 44,952
2022-06-30 $840,548 116,098
2022-03-31 $1,340,844 103,861
2021-12-31 $2,612,524 163,692
2021-09-30 $1,972,785 122,762
2021-06-30 $727,236 52,584
2021-03-31 $1,771,052 121,222
2020-12-31 $221,768 12,760
2020-09-30 $297,749 16,235
2020-06-30 $431,389 24,154
2020-03-31 $337,407 20,802
2020-03-31 $324,400 20,000